Infected children may harbor SARS-CoV-2 while showing less-severe symptoms than adults. Their young immune systems, ACE2 receptor levels, and even exposure to other coronaviruses might play a role in their resilience.

Disease experts have largely focused on how we got to where we are now with coronavirus infections. Improved data collection and sharing can enhance projections of what’s to come.

Current methods to detect infections of the novel coronavirus rely on identifying particular genetic sequences, but new assays are being developed to meet the growing demand for rapid answers.

Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.

Scientists’ latest understanding of the facts, the suspicions, and the discounted rumors of SARS-CoV-2’s transmission from person to person

Scientists are using social media to track diseases and understand how people respond to them.

A technique called Mendelian randomization is overturning the conclusions of observational studies in public health. But researchers question whether the method can overcome its fundamental limitations.

Political newcomers to federal and state legislatures with STEM backgrounds are bringing evidence to drafting laws, yet getting bills passed remains elusive.

Health officials are rushing a genetically engineered product into the field to counter uncontained outbreaks of vaccine-derived polio.